Anne Margulies
HENRY SCHEINAbout Anne H. Margulies
Anne H. Margulies (age 69) has served as an independent director of Henry Schein, Inc. since 2018. She is the former Vice President and Chief Information Officer of Harvard University (2010–2021), previously CIO for the Commonwealth of Massachusetts (2007–2010), and Founding Executive Director of MIT OpenCourseWare (2002–2007). Education: B.A., State University of New York at Plattsburgh. Core credentials: over 35 years in strategic IT, cybersecurity, and policy/risk management; leadership of Harvard University Information Technology (HUIT) with a ~$200 million budget and ~700 staff.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Harvard University | Vice President & Chief Information Officer | 2010–2021 | Led HUIT, oversaw ~$200M budget and ~700 staff; responsible for IT strategy, policies, and services supporting teaching, learning, and research. |
| Commonwealth of Massachusetts | Chief Information Officer (Assistant Secretary for IT) | 2007–2010 | Developed statewide strategic IT plan; consolidated agency IT operations, data centers, and networks into a coherent statewide structure (national acclaim). |
| MIT OpenCourseWare | Founding Executive Director | 2002–2007 | Launched MIT’s OCW initiative; Founding Chair of the International OpenCourseWare Consortium (300+ universities globally). |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| HarborOne Bancorp, Inc. | Director | 2022–Present | Compensation Committee member; Nominating & Governance Committee member. |
| Standard BioTools Inc. (f.k.a. SomaLogic, Inc.) | Director | 2019–Jan 2024 | Compensation Committee Chair; Nominating & Governance Committee member; Audit Committee member. |
| Curry College | Board of Trustees | Not disclosed | Trustee. |
| Advanced Cyber Security Center | Advisory Board Member | Not disclosed | Regional cybersecurity collaboration/defense advisory. |
| Massachusetts Cybersecurity Strategy Council | Member | 2017–2021 | State cyber strategy engagement. |
| BostonCIO | Advisory Board Member; Former Chair | 2015–2021 | CIO leadership network. |
| International OpenCourseWare Consortium | Founding Chair | Not disclosed | Global open education collaboration. |
Board Governance
- Committee assignments: Audit Committee member; Regulatory, Compliance and Cybersecurity Committee member. Not listed as chair of either committee.
- Independence: Board affirmed Ms. Margulies is independent under Nasdaq Rule 5605(a)(2).
- Attendance: In fiscal 2024, the Board met 9 times; each director attended at least 75% of Board and applicable committee meetings. Ms. Margulies attended the 2024 Annual Meeting of Stockholders.
- Committee activity levels (FY 2024): Audit (5 meetings); Compensation (8); Nominating & Governance (2); Regulatory, Compliance & Cybersecurity (6); Strategic Advisory (3).
- Audit oversight: Audit Committee (including Ms. Margulies) reviewed FY2024 audited financials, internal controls, and auditor independence; recommended inclusion of audited financials in the 10-K.
- Related party review: Audit Committee reviews and approves related party transactions per charter.
Fixed Compensation
| Component | FY 2024 | Notes |
|---|---|---|
| Annual Cash Fees | $135,200 | Base annual retainer increased to $100,000 for FY 2024 (from $90,000); $2,200 paid per committee meeting; additional $2,200 per meeting for Audit and Regulatory Committee members conducting review of the Oct 2023 cybersecurity incident. |
| Meeting Fees (per committee meeting) | $2,200 | Applies to all committee meetings; special incident review meetings paid at same rate. |
| Chair Retainers | $0 | Not a committee chair; chair retainer levels are $15,000 (Nominating, Regulatory, Strategic), $20,000 (Compensation), $25,000 (Audit). |
| Other Cash/Perquisites | $0 | No other cash reported for FY 2024. |
Performance Compensation
| Component | FY 2024 | Structure/Metrics |
|---|---|---|
| Stock Awards (RSUs) – Grant Date Fair Value | $200,000 | Valued per FASB ASC 718; RSUs vest per plan; not reduced for deferral elections. |
| Options | $0 | Company does not grant options to non-employee directors. |
| Annual Bonus (Non-Equity Incentive) | $0 | Company does not grant performance-based annual incentives to non-employee directors. |
Performance metrics tied to director compensation:
| Metric Category | Details |
|---|---|
| Performance-based elements | None – non-employee directors do not receive performance-based incentives. |
Other Directorships & Interlocks
| Company | Sector | Role | Potential Interlock/Conflict |
|---|---|---|---|
| HarborOne Bancorp, Inc. | Regional Banking | Director; Comp & Nominating/Govt Committees | No Henry Schein-related transactions disclosed; Audit Committee oversees related party approvals. |
| Standard BioTools Inc. (f.k.a. SomaLogic, Inc.) | Life Sciences Tools | Director (2019–Jan 2024); Comp Chair; Nom/Gov; Audit | No Henry Schein-related transactions disclosed; tenure ended Jan 2024. |
Expertise & Qualifications
- Technology and cybersecurity leadership: 35+ years; Harvard CIO role included cybersecurity risk management at scale (30,000 constituents; $200M budget; 700 staff).
- Public company governance: Board and committee experience at HarborOne (Comp; Nom/Gov) and Standard BioTools/SomaLogic (Comp Chair; Nom/Gov; Audit).
- Public sector strategy: Massachusetts CIO; led statewide IT consolidation and strategic planning.
- Recognitions: 2015 Boston CIO Leader of the Year; 2017 CIO Hall of Fame; Honorary Doctorate (2019).
Equity Ownership
| Ownership Detail | FY 2024 Year-End | As of March 24, 2025 |
|---|---|---|
| Direct shares | Not disclosed | 12,815 shares |
| Deferred Compensation Plan (phantom share account) | Not disclosed | 7,430 shares |
| Vested RSUs – payment date deferred | 10,679 RSUs | 4,917 RSUs |
| Unvested RSUs outstanding | 2,604 RSUs (per director) | Not disclosed |
| Total beneficial ownership | Not disclosed | 25,162 shares; less than 0.50% of class |
| Ownership guidelines | Must hold ≥10,000 shares or ≥5x annual retainer ($100,000) | All non-employee directors in compliance |
| Anti-hedging/anti-pledging | Prohibited for non-employee directors | Prohibited |
Note: Differences in deferred RSU counts reflect distinct “as-of” dates (FY 2024 year-end vs. March 24, 2025).
Governance Assessment
- Board effectiveness: Strong cyber and IT risk oversight through dual membership on Audit and Regulatory, Compliance & Cybersecurity Committees, with tangible engagement during the 2023 cybersecurity incident review (paid meeting participation).
- Independence and alignment: Independent under Nasdaq; complies with stringent stock ownership policy; anti-hedging/pledging policy enhances alignment.
- Attendance and engagement: Board and committee cadence is robust; all directors met the ≥75% attendance threshold; Ms. Margulies attended the 2024 Annual Meeting, signaling engagement with investors.
- Compensation mix: Balanced cash/equity with no performance-based incentives for directors; equity via RSUs provides ongoing alignment; cash retainer increased to remain competitive, with transparent caps on total director compensation.
- Conflicts and related-party exposure: No related-party transactions involving Ms. Margulies disclosed; Audit Committee processes in place to review and approve any such transactions.
RED FLAGS
- None disclosed regarding related-party transactions, hedging/pledging, or low attendance for Ms. Margulies.